Cargando…
Factors associated with the uptake of biosimilars for breast cancer treatment from the perspectives of physicians and patients-Evidence from China
Objective: To investigate the factors associated with the treatment of breast cancer with biosimilars from the perspectives of physicians and patients, and to generate evidence for promoting the uptake of biosimilars. Methods: This study targeted trastuzumab and its indicated human epidermal growth...
Autores principales: | Wu, Qiyou, Lian, Zhiwei, Wang, Xin, Cheng, Hanchao, Sun, Jing, Yu, Hui, Zhang, Gong, Wu, Fan, Liu, Jian, Chen, Chuanben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877225/ https://www.ncbi.nlm.nih.gov/pubmed/36712662 http://dx.doi.org/10.3389/fphar.2022.1044798 |
Ejemplares similares
-
Switching Among Biosimilars: A Review of Clinical Evidence
por: Allocati, Eleonora, et al.
Publicado: (2022) -
Key concepts in biosimilar medicines: What physicians must know
por: Iskit, Alper B.
Publicado: (2022) -
Physicians’ perceptions of the uptake of biosimilars: a systematic review
por: Sarnola, Kati, et al.
Publicado: (2020) -
The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors
por: Fabiani, Claudia, et al.
Publicado: (2019) -
Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?
por: Kim, Yujeong, et al.
Publicado: (2020)